4.6 Article

WhiB4 Is Required for the Reactivation of Persistent Infection of Mycobacterium marinum in Zebrafish

期刊

MICROBIOLOGY SPECTRUM
卷 10, 期 2, 页码 -

出版社

AMER SOC MICROBIOLOGY
DOI: 10.1128/spectrum.00443-21

关键词

WhiB4; latency; reactivation; tuberculosis; zebrafish

资金

  1. National Key R&D Program of China [2018YFD0500900]
  2. China's 13th Five Year Programs for the prevention and cure of great infectious diseases [2017ZX10201301-005]
  3. Canadian Institutes of Health Research (CIHR) [PJT-156261, PJT-173353]

向作者/读者索取更多资源

WhiB4 plays a critical role in the disease progression and reactivation of Mycobacterium marinum infection. Targeting WhiB4 may be a promising strategy for the development of novel therapeutics to prevent the reactivation of latent tuberculosis infection.
Granulomas are the pathological hallmark of tuberculosis (TB). In individuals with latent TB infection, Mycobacterium tuberculosis cells reside within granulomas in a nonreplicating dormant state, and a portion of them will develop active TB. Little is known on the bacterial mechanisms/factors involved in this process. In this study, we found that WhiB4, an oxygen sensor and a transcription factor, plays a critical role in disease progression and reactivation of Mycobacterium marinum (M. marinum) infection in zebrafish. We show that the whiB4::Tn mutant of M. marinum caused persistent infection in adult zebrafish, which is characterized by the lower but stable bacterial loads, constant number of nonnecrotized granulomas in fewer organs, and reduced inflammation compared to those of zebrafish infected with the wild-type bacteria or the complemented strain. The mutant bacteria in zebrafish were also less responsive to antibiotic treatments. Moreover, the whiB4::Tn mutant was defective in resuscitation from hypoxia-induced dormancy and the DosR regulon was dysregulated in the mutant. Taken together, our results suggest that WhiB4 is a major driver of reactivation from persistent infection. IMPORTANCE About one-quarter of the world's population has latent TB infection, and 5 to 10% of those individuals will fall ill with TB. Our finding suggests that WhiB4 is an attractive target for the development of novel therapeutics, which may help to prevent the reactivation of latent infection, thereby reducing the incidences of active TB.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据